[(Scheme_2)TD$FIG]
P. Kumar, A. Kumar / Chinese Chemical Letters 21 (2010) 1287–1290
1289
Scheme 2.
References
[1] (a) R.E. Sammelson, T. Ma, L.J.V. Galietta, et al. Bioorg. Med. Chem. Lett. 13 (2003) 2509;
(b) G. Bal, P.V. Venken, D. Antonov, et al. Bioorg. Med. Chem. Lett. 13 (2003) 2875;
(c) A. Lang, Y. Lin, in: A.R. Katrizky (Ed.), Comprehensive Heterocyclic Chemistry, vol. 6, Pergamon Press, Oxford, 1984, p. 1;
(d) K.J. Hwang, H.J. Kim, J.H. Lee, Korean J. Med. Chem. 4 (1994) 2.
[2] (a) A. Quilico, in: R.H. Wiley (Ed.), Five and Six Membered Compound with Nitrogen and Oxygen, Wiley Interscience, 1962, p. 1;
(b) B.J. Wakefield, D.J. Wright, Adv. Heterocycl. Chem. 25 (1979) 147;
(c) P. Krogsgaard-Larsen, L. Brehm, K. Schaumberg, Acta Chem. Scand. B 35 (1981) 311;
(d) D.G. Martin, D.J. Duchamp, C.G. Chidester, Tetrahedron Lett. 14 (1973) 2549;
(e) T. Kusumi, C.C. Chang, M. Wheeler, et al. Tetrahedron Lett. 22 (1981) 3451;
(f) A.P. Kozikowski, Acc. Chem. Res. 17 (1984) 410;
(g) B.B. Shankar, D.Y. Yang, S. Girton, et al. Tetrahedron Lett. 39 (1998) 2447.
[3] (a) V. Nair, J. Matthew, J. Prabhakaran, Chem. Soc. Rev. 26 (1997) 127;
(b) J.R. Hwu, K.Y. King, Curr. Sci. 81 (2001) 1043;
(c) V. Nair, S.B. Panicker, L.G. Nair, et al. Synlett (2003) 156.
[4] T. Sugai, N. Watanabe, H. Ohta, Tetrahedron: Asymmetry 2 (1991) 371.
[5] (a) S.C. Roy, C. Guin, K.K. Rana, et al. Synlett (2001) 226;
(b) S.C. Roy, B. Banerjee, Synlett (2002) 1677.
[6] (a) S.Y. Wang, S.J. Ji, Tetrahedron 62 (2006) 1527;
(b) G. Savitha, P.T. Perumal, Tetrahedron Lett. 47 (2006) 3589;
(c) V. Nair, K. Mohanan, T.D. Suja, et al. Tetrahedron Lett. 47 (2006) 705;
(d) R. Varala, R. Enugala, S. Nuvula, et al. Synlett (2006) 1009;
(e) V. Sridharan, C. Avendano, J.C. Menendez, Tetrahedron 63 (2007) 673.
[7] E.V. DehmLow, J.K. Makrandi, J. Chem. Res. (S) (1986) 32.
[8] B.K. Mishra, M. Kunar, A. Sharma, B.B. Nayak, Indian J. Chem. 40B (2001) 724.
[9] Synthesis of cetyltrimethylammonium cerium (IV) nitrate: Cerium (IV) ammonium nitrate (0.01 mol) in 10 mL water was added slowly to an
aqueous solution of cetyltrimethylammonium bromide (0.025 mol) with continuous stirring on a magnetic stirrer. Ayellow coloured compound
appeared slowly. Stirring was continued for 30 min. The resulting yellow coloured compound was filtered with water for several times till no
trace of bromide ion was detected in the filtrate. It was vacuum dried and kept in a dark bottle inside desiccator, yield 93%. Anal. Calcd. for
C38H84N8O15Ce: C, 42.22; H, 7.77; N, 13.37. Found: C, 42.50; H, 7.96; N, 13.32%.
[10] General experimental procedure for synthesis of 3: An aldoxime 1 (1.0 mmol) and methyl acrylate/acrylonitrile/vinyl acetate (1.2 mmol) were
taken in anhydrous CH2Cl2 (25 mL). Cetyltrimethylammonium cerium nitrate (2.36 g, 2.2 mmol) was added and the reaction mixture was
stirred at room temperature for the time as indicated in Table 1. The reaction was monitored by TLC. After completion, water (20 mL) was
added and shaken well. Separated the organic layer and again washed with water (10 mL), dried over MgSO4 and concentrated. The residue
was subjected to column chromatography over silica gel using hexane–ethylacetate (5:2) as eluent to obtain pure isoxazoline 3. Spectral data of
synthesized oxazoline are given below: 3a 1H NMR (CDCl3, 400 MHz): d 8.46 (d, 1H, J = 2.1 Hz), 8.35 (dd, 1H, J = 8.0, 2.1 Hz), 8.09 (dd, 1H,
J = 8.0, 2.0 Hz), 7.69 (m, 1H), 5.48 (dd, 1H, J = 8.0, 5.8 Hz), 3.83 (dd, 1H, J = 11.5, 8.0 Hz), 3.71 (dd, 1H, J = 11.5, 5.8 Hz); MS (EI): m/z
217.05 (Mꢀ+) (Found: C, 55.39; H, 3.33; N, 19.27. C10H7N3O3 requires: C, 55.30; H, 3.25; N, 19.35%). 3b 1H NMR (CDCl3, 400 MHz): d 7.74
(dd, 1H, J = 7.9, 2.2 Hz), 7.50–7.28 (m, 3H), 5.38 (dd, 1H, J = 8.0, 4.3 Hz), 3.94 (dd, 1H, J = 11.6, 8.0 Hz), 3.79 (dd, 1H, J = 11.6, 4.3 Hz); MS
1
(EI): m/z 206.02, 208.02 (Mꢀ+) (Found: C, 58.23; H, 3.37; N, 13.44. C10H7ClN2O. requires: C, 58.13; H, 3.41; N, 13.56; %). 3c H NMR
(CDCl3, 400 MHz): d 7.76 (m, 2H), 7.45 (m, 3H), 5.35 (dd, 1H, J = 8.0, 5.7 Hz), 3.83 (dd, 1H, J = 11.5, 8.0 Hz), 3.71 (dd, 1H, J = 11.5,
5.7 Hz); MS (EI): m/z 172.06 (Mꢀ+) (Found: C, 69.64; H, 4.78; N, 16.32. C10H8N2O requires: C, 69.76; H, 4.68; N, 16.27%). 3d 1H NMR
(CDCl3, 400 MHz): d 8.44 (d, 1H, J = 2.2 Hz), 8.30 (dd, 1H, J = 8.0, 2.2 Hz), 8.10 (dd, 1H, J = 8.0, 2.0 Hz), 7.68 (m, 1H), 5.28 (dd, 1H,
J = 8.2, 3.8 Hz), 3.83 (s, 3H), 3.78 (dd, 1H, J = 11.5, 8.2 Hz), 3.62 (dd, 1H, J = 11.5, 3.8 Hz); MS (EI): m/z 250.06 (Mꢀ+) (Found: C, 52.92; H,
4.12; N, 11.24. C11H10N2O5 requires: C, 52.80; H, 4.03; N, 11.20%). 3e 1H NMR (CDCl3, 400 MHz): d 7.73 (dd, 1H, J = 7.9, 2.2 Hz), 7.42–
7.25 (m, 3H), 5.16 (dd, 1H, J = 7.9, 3.9 Hz), 3.79 (dd, 1H, J = 11.6, 7.9 Hz), 3.62 (dd, 1H, J = 11.6, 3.9 Hz), 3.85 (s, 3H); MS (EI): m/z 239.03,
241.03 (Mꢀ+) (Found: C, 55.22; H, 4.27; N, 5.74. C11H10ClNO3 requires: C, 55.13; H, 4.21; N, 5.84%). 3f 1H NMR (CDCl3, 400 MHz): d 7.76
(d, 2H, J = 7.5 Hz), 7.45 (m, 3H), 5.17 (dd, 1H, J = 8.1, 4.2 Hz), 3.79 (dd, 1H, J = 11.6, 8.1 Hz), 3.62 (dd, 1H, J = 11.6, 4.2 Hz), 3.85 (s, 3H);
MS (EI): m/z 205.07 (Mꢀ+) (Found: C, 64.45; H, 5.51; N, 7.02. C11H11NO3 requires: C, 64.38; H, 5.40; N, 6.83%). 3g 1H NMR (CDCl3,
400 MHz): d 8.45 (d, 1H, J = 2.2 Hz), 8.30 (dd, 1H, J = 8.0, 2.2 Hz), 8.09 (dd, 1H, J = 8.0, 2.0 Hz), 7.67 (m, 1H), 6.83 (dd, 1H, J = 8.2,
3.8 Hz), 3.68 (dd, 1H, J = 11.5, 8.2 Hz), 3.40 (dd, 1H, J = 11.5, 3.8 Hz), 2.12, (s, 3H); MS (EI): m/z 250.06 (Mꢀ+) (Found: C, 52.94; H, 3.97; N,